Company name
Parexel Biotech
Company profile
Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients.
Date, time and room information
Monday, May 4, 15:15 - 15:30, room Sydney
Category
Commercial stage company
Title of the presentation
Common pitfalls in RWE studies – A regulator’s insights and recommendations
Speaker information
| Name | Position | Institution |
|---|---|---|
| Sinan Sarac | Senior Vice President, Head of Oncology Europe, Regulatory Consulting | Parexel |
